Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system.

Neale JH, Bzdega T, Wroblewska B.

J Neurochem. 2000 Aug;75(2):443-52. Review.

2.

Application of Novel Therapeutic Agents for CNS Injury: NAAG Peptidase Inhibitors.

Lyeth BG.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 38.

3.

Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.

Neale JH, Olszewski RT, Zuo D, Janczura KJ, Profaci CP, Lavin KM, Madore JC, Bzdega T.

J Neurochem. 2011 Aug;118(4):490-8. doi: 10.1111/j.1471-4159.2011.07338.x. Epub 2011 Jul 1. Review.

4.

NAAG, NMDA receptor and psychosis.

Bergeron R, Coyle JT.

Curr Med Chem. 2012;19(9):1360-4. Review.

5.

The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.

Neale JH, Olszewski RT, Gehl LM, Wroblewska B, Bzdega T.

Trends Pharmacol Sci. 2005 Sep;26(9):477-84. Review.

PMID:
16055199
6.

Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia.

Tsai SJ.

Med Sci Monit. 2005 Sep;11(9):HY39-45. Epub 2005 Aug 26. Review.

PMID:
16127367
7.
8.

Amino acids are still as exciting as ever.

Carpenter KJ, Dickenson AH.

Curr Opin Pharmacol. 2001 Feb;1(1):57-61. Review.

PMID:
11712536
9.

The nagging question of the function of N-acetylaspartylglutamate.

Coyle JT.

Neurobiol Dis. 1997;4(3-4):231-8. Review.

PMID:
9361299
10.

Blockade of N-acetylaspartylglutamate peptidases: a novel protective strategy for brain injuries and neurological disorders.

Zhong C, Luo Q, Jiang J.

Int J Neurosci. 2014 Dec;124(12):867-73. doi: 10.3109/00207454.2014.890935. Epub 2014 Feb 13. Review.

PMID:
24494725
11.

The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target.

Baslow MH.

Drug News Perspect. 2008 Jun;21(5):251-7. doi: 10.1358/dnp.2008.21.5.1216215. Review.

PMID:
18596989
12.
14.

[Neurotransmitters, calcium signalling and neuronal communication].

Eguiagaray JG, Egea J, Bravo-Cordero JJ, García AG.

Neurocirugia (Astur). 2004 Apr;15(2):109-18. Review. Spanish.

17.

Cellular physiology of hypoxia of the mammalian central nervous system.

Somjen GG, Aitken PG, Czéh G, Jing J, Young JN.

Res Publ Assoc Res Nerv Ment Dis. 1993;71:51-65. Review.

PMID:
8380239
18.

Functional consequences of neuropeptide and small-molecule co-transmission.

Nusbaum MP, Blitz DM, Marder E.

Nat Rev Neurosci. 2017 Jul;18(7):389-403. doi: 10.1038/nrn.2017.56. Epub 2017 Jun 8. Review.

PMID:
28592905
19.

A novel key-lock mechanism for inactivating amino acid neurotransmitters during transit across extracellular space.

Baslow MH.

Amino Acids. 2010 Jan;38(1):51-5. doi: 10.1007/s00726-009-0232-0. Epub 2009 Jan 17. Review.

PMID:
19151913
20.

Supplemental Content

Support Center